COBENFY™ (xanomeline and trospium chloride) is a prescription medicine used to treat schizophrenia in adults. It is not known ...

Survey data showed that a third of Parkinson's patients reported a cognitive symptom soon after diagnosis. Most common were problems with memory, language or word finding, and concentration or ...

Researchers discovered that clogged brain “drains” show up early in people at risk of Alzheimer’s disease. These blockages, ...

Memory and cognitive symptoms were tied to self-reported sleep apnea, cross-sectional data from the National Health and Nutrition Examination Survey (NHANES) showed. In a survey of more than 4,200 U.S ...

Over 2.3 million people worldwide are living with relapsing multiple sclerosis (RMS), and close to half of those are in the US. Unlike some other debilitating diseases, RMS impacts every patient ...

An estimated 16.9 million cancer survivors have reported cognitive deficits, which can interfere with everyday activities. Cognitive impairment may include difficulty with memory, attention, language, ...

Cognitive dysfunction in kidney cancer survivors is linked to treatment burden, stress, and fatigue, affecting daily ...

An analysis of major depressive disorder, covering diagnostic criteria, prevalence statistics across demographics, and ...

With the coronavirus disease 2019 (COVID-19) pandemic, most infections are asymptomatic or mild, but a significant minority develop severe symptoms. Some earlier studies have indicated that initial ...

Researchers are slowly tossing much of what we've been told for many years about Alzheimer's disease out the window — and replacing what has been a very dreary tale with new findings.